Food and Drug Administration

AG Paxton to Investigate Promotion of Puberty Blockers in Children

Attorney General Ken Paxton

Attorney General Ken Paxton is investigating Endo Pharmaceuticals, Inc., and AbbVie Inc. under the Texas Deceptive Trade Practices Act. These pharmaceutical companies allegedly advertised and promoted hormone (puberty) blockers for unapproved uses without disclosing the potential risks associated with these drugs to children and their parents. Medications Supprelin LA and Lupron Depot are approved to treat children with Central Precocious Puberty (CPP), when the puberty process begins prematurely. And Vantas, along with other forms of Lupron, has been […]

CONSUMER ALERT: Be Cautious When Purchasing Over-the-Counter Hearing Aids

Ken Paxton

Attorney General Ken Paxton today warned Texans to be cautious when considering buying from companies selling over-the-counter hearing aids, particularly online or by mail order. Many hearing devices sold this way are not approved by the Food and Drug Administration (FDA) and are deceptively marketed as medical hearing devices when they contain low-quality amplifiers. Texans should remember these tips when purchasing a hearing aid: Get a hearing screening and recommendation from a hearing professional who can […]